Individual generic drug information
Extracted information for Bosentan only.
Pulmonary arterial hypertension (initiated under Cardiovascular system specialist supervision) ▶BY MOUTH ▶Adult: Initially 62.5 mg twice daily for 4 weeks, then increased to 125 mg twice daily (max. per dose 250 mg); maximum 500 mg per day Systemic sclerosis with ongoing digital ulcer disease (to reduce number of new digital ulcers) ▶BY MOUTH ▶Adult: Initially 62.5 mg twice daily for 4 weeks, then increased to 125 mg twice daily
Source page 217
Acute porphyrias p. 1120
Source page 217
Not to be initiated if systemic systolic blood pressure is below 85 mmHg. pulmonary veno-occlusive disease
Source page 217
Extracted information for Bosentan only.
→Appendix 1: bosentan
Source page 217
▶Common or very common Anaemia. diarrhoea. flushing. gastrooesophageal reflux disease. headache. nasal congestion. palpitations. skin reactions. syncope ▶Uncommon Hepatic disorders. leucopenia. neutropenia. thrombocytopenia ▶Rare or very rare Angioedema ▶Frequency not known Vision blurred
Source page 217
Effective contraception required during administration (hormonal contraception not considered effective). Monthly pregnancy tests advised.
Source page 217
Avoid (teratogenic in animal studies).
Source page 217
Manufacturer advises avoid—no information available.
Source page 217
Manufacturer advises avoid in moderate-to-severe impairment or if baseline serum transaminases exceed 3 times the upper limit of normal.
Source page 217
▶Monitor haemoglobin before and during treatment (monthly for first 4 months, then 3-monthly). ▶Monitor liver function before treatment, at monthly intervals during treatment, and 2 weeks after dose increase (reduce dose or suspend treatment if liver enzymes raised significantly)—discontinue if symptoms of liver impairment.
Source page 217
Extracted information for Bosentan only.
There can be variation in the licensing of different medicines containing the same drug. Tablet ▶Bosentan (Non-proprietary) Bosentan (as Bosentan monohydrate) 62.5 mg Bosentan 62.5mg tablets | 56 tablet P £112.50 (Hospital only) | 56 tablet P £1,359.19–£1,510.21 Bosentan (as Bosentan monohydrate) 125 mg Bosentan 125mg tablets | 56 tablet P £112.50 (Hospital only) | 56 tablet P £1,359.19–£1,510.21 ▶Stayveer (Advanz Pharma) Bosentan (as Bosentan monohydrate) 62.5 mg Stayveer 62.5mg tablets | 56 tablet P £208.34 Bosentan (as Bosentan monohydrate) 125 mg Stayveer 125mg tablets | 56 tablet P £208.34 ▶Tracleer (Actelion Pharmaceuticals UK Ltd) Bosentan (as Bosentan monohydrate) 62.5 mg Tracleer 62.5mg tablets | 56 tablet P £1,510.21 Bosentan (as Bosentan monohydrate) 125 mg Tracleer 125mg tablets | 56 tablet P £1,510.21
Source page 217
Extracted information for Bosentan only.
Avoid abrupt withdrawal— withdraw treatment gradually.
Source page 217
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
Initially 62.5 mg twice daily for 4 weeks, then
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 217
First line only; read the complete Indications and dose section above.
Initially 62.5 mg twice daily for 4 weeks, then
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 217
